Sir Peter Karel, Baron Piot is a Belgian-British microbiologist known for his research into Ebola and AIDS.
Lawrence Oglethorpe Gostin is an American law professor who specializes in public health law. He was a Fulbright Fellow and is best known as the author of the Model State Emergency Health Powers Act and as a significant contributor to journals on medicine and law.
Pharmacoeconomics refers to the scientific discipline that compares the value of one pharmaceutical drug or drug therapy to another. It is a sub-discipline of health economics. A pharmacoeconomic study evaluates the cost and effects of a pharmaceutical product. Pharmacoeconomic studies serve to guide optimal healthcare resource allocation, in a standardized and scientifically grounded manner.
Health policy can be defined as the "decisions, plans, and actions that are undertaken to achieve specific healthcare goals within a society". According to the World Health Organization, an explicit health policy can achieve several things: it defines a vision for the future; it outlines priorities and the expected roles of different groups; and it builds consensus and informs people.
The United States Preventive Services Task Force (USPSTF) is "an independent panel of experts in primary care and prevention that systematically reviews the evidence of effectiveness and develops recommendations for clinical preventive services". The task force, a volunteer panel of primary care clinicians with methodology experience including epidemiology, biostatistics, health services research, decision sciences, and health economics, is funded, staffed, and appointed by the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality.
Health technology assessment (HTA) is a multidisciplinary process that uses systematic and explicit methods to evaluate the properties and effects of a health technology. Health technology is conceived as any intervention at any point in its lifecycle. The purpose of HTA is to inform "decision-making in order to promote an equitable, efficient, and high-quality health system". It has other definitions including "a method of evidence synthesis that considers evidence regarding clinical effectiveness, safety, cost-effectiveness and, when broadly applied, includes social, ethical, and legal aspects of the use of health technologies. The precise balance of these inputs depends on the purpose of each individual HTA. A major use of HTAs is in informing reimbursement and coverage decisions by insurers and national health systems, in which case HTAs should include benefit-harm assessment and economic evaluation." And "a multidisciplinary process that summarises information about the medical, social, economic and ethical issues related to the use of a health technology in a systematic, transparent, unbiased, robust manner. Its aim is to inform the formulation of safe, effective, health policies that are patient focused and seek to achieve best value. Despite its policy goals, HTA must always be firmly rooted in research and the scientific method".
The National Institute for Health and Care Research (NIHR) is the British government's major funder of clinical, public health, social care and translational research. With a budget of over £1.2 billion in 2020–21, its mission is to "improve the health and wealth of the nation through research". The NIHR was established in 2006 under the government's Best Research for Best Health strategy, and is funded by the Department of Health and Social Care. As a research funder and research partner of the NHS, public health and social care, the NIHR complements the work of the Medical Research Council. NIHR focuses on translational research, clinical research and applied health and social care research.
David M. Eddy is an American physician, mathematician, and healthcare analyst who has done seminal work in mathematical modeling of diseases, clinical practice guidelines, and evidence-based medicine. Four highlights of his career have been summarized by the Institute of Medicine of the National Academy of Sciences: "more than 25 years ago, Eddy wrote the seminal paper on the role of guidelines in medical decision-making, the first Markov model applied to clinical problems, and the original criteria for coverage decisions; he was the first to use and publish the term 'evidence-based'."
Sir Michael David Rawlins was a British clinical pharmacologist and emeritus professor at the University of Newcastle upon Tyne. During his medical career he chaired several executive agencies including the Committee on Safety of Medicines from 1993 to 1998, followed by the National Institute for Health and Care Excellence (NICE) for 14 years from its formation in 1999 and then the Medicines and Healthcare products Regulatory Agency (MHRA) for six years from 2014. From 2012 to 2014 he was president of the Royal Society of Medicine.
Gillian Catherine Leng, Lady Cosford CBE is a British health administrator, academic, visiting professor at King's College London and the former Chief Executive of the National Institute for Health and Care Excellence (NICE), where she was responsible for several programmes and guidelines including the guidelines on COVID-19. In 2024 she became president of the Royal Society of Medicine (RSM).
Louis Preston Garrison Jr. is an American health economist who has made significant contributions to pharmacoeconomics, pharmacogenomics and personalized medicine, regulatory benefit-risk analysis, insurance, pricing, reimbursement and risk-sharing agreements. He also made numerous contributions on the economic evaluation of pharmaceuticals, diagnostics, devices, surgical procedures, and vaccines, particularly as related to organ transplantation, influenza, measles, obesity, and cancer. Garrison has published over a hundred manuscripts in peer-reviewed journals and contributed to several book chapters.
ISPOR—The Professional Society for Health Economics and Outcomes Research, also known as ISPOR is a global, nonprofit 501(c)(3) public organization for educational and scientific purposes, as defined by the United States Internal Revenue Service.
John Norman Lavis is a Canadian physician based in Toronto, Ontario. He is a tenured professor in the Department of Health Evidence and Impact at McMaster University, where he founded and directs the McMaster Health Forum. He is co-lead of Rapid-Improvement Support and Exchange (RISE).
Jocalyn Clark is a Canadian Public Health Scientist and the International Editor of The BMJ, with responsibility for strategy and internationalising the journal's content, contributors and coverage. From 2016 to 2022, Jocalyn was an Executive Editor at The Lancet, where she led the Commentary section, coordinated peer review, and edited and delivered collections of articles and Commissions on topics such as maternal and child health, oral health, migration, end of life care and gender equity. She led the Lancet's project to advance women in science, medicine, and global health, #LancetWomen. She is also an adjunct professor of Medicine at the University of Toronto and an Honorary Associate Professor at the Institute for Global Health at UCL.
Helena Legido-Quigley is a Spanish public health researcher who is an associate professor in Health Systems at Saw Swee Hock School of Public Health at the National University of Singapore. She serves as an associate fellow of Chatham House and is a member of the Council of the World Economic Forum. She is editor-in-chief of Elsevier's Journal of Migration and Health.
Saskia Popescu is an infectious disease epidemiologist and global health security expert in Phoenix, Arizona. She is an Assistant Professor of epidemiology at the University of Maryland, and holds academic appointments at the University of Arizona and George Mason University’s Schar School of Policy and Government, where she lectures on biopreparedness and outbreak response. Since the start of the Coronavirus disease 2019 pandemic, Popescu has worked to prepare for and mitigate the spread of the disease within healthcare and the entertainment industry, where she led the global epidemiology and infection prevention response for Netflix. She has been recognized for her communication efforts around the pandemic, as well as her work on the front lines in infection prevention and healthcare biopreparedness. Popescu currently is a Policy Researcher at RAND Corporation, addressing converging biological risks from biological weapons nonproliferation, biosecurity, emerging infectious diseases and ecological security, biopreparedness in private industry, and global health security vulnerabilities.
The Abdul Latif Jameel Institute for Disease and Emergency Analytics is a research institute at Imperial College London in the fields of epidemiology, mathematical modelling of infectious diseases and emergencies, environmental health, and health economics. Co-founded in 2019 by Imperial College London and Community Jameel, the Jameel Institute is housed in the School of Public Health, within the college's Faculty of Medicine. The mission of the Jameel Institute is "to combat threats from disease worldwide".
The Institute of Global Health Innovation is one of Imperial College London’s global challenge Institutes. Established in 2010, its mission is to improve global health and care through evidence-based innovation. The Institute’s work aims to support the identification, development and implementation of healthcare innovation, with the goal of sustainably reducing inequalities in global health.
Kirsten McCaffery is a British-Australian public health researcher who is Principal Research Fellow and Director of Research at the Sydney School of Public Health. Her research considers the psychosocial aspects of over diagnosis in healthcare. She was elected Fellow of the Australian Academy of Health and Medical Sciences in 2020.
Suerie Moon is an American public health expert who is Professor of Practice at the Graduate Institute of International and Development Studies. Her research considers global health, health equity and pandemic preparedness.
